European Case Law Identifier: | ECLI:EP:BA:2009:T045807.20090923 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 23 September 2009 | ||||||||
Case number: | T 0458/07 | ||||||||
Application number: | 99921610.4 | ||||||||
IPC class: | C07K 1/18 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Protein purification by ion exchange chromatography | ||||||||
Applicant name: | Genentech, Inc. | ||||||||
Opponent name: | Novo Nordisk A/S | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Added subject-matter (no) Sufficiency of disclosure, novelty, inventive step (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t070458eu1.html
Date retrieved: 17 May 2021